Applying the regenerative medicine to cure the side-effects causing by the chemo/radiation therapy such as oral mucositis
Applying the regenerative medicine to cure the side-effects causing by the chemo/radiation therapy such as oral mucositis
批准号:
23659921
负责人:
OKUMURA Teruhito
金额:
$2.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oral mucositis is a serious and painful side effect for patients with head and neck cancer who received radiation- and/or chemo-therapy. It causes not only the limitation on the ability of patients to tolerate cancer therapies in some cases but also the harmful effects on the quality of life. However, current clinical strategies cannot efficiently prevent the occurrence of oral mucositis. Therefore, effectivetherapy should be developed urgently. BMDCs isolated from male C3H mice were transplanted to the female mice just after the irradiation through the tail vein. After 2, 5, 7 and 11 days of irradiation, the tongues were harvested, and the macroscopic, histological and immunological analyses were performed to clarify the effects of BMDC transplantation. After 2 days of irradiation, the tongues of non-treated mice (IR) showed significant apoptosis of the cells throughout the basal cell layer while few cells were observed in that of BMDCs-treated mice (BM). After 7 days of irradiation, while the ulcer area became maximum in the tongues of IR, the area of ulcers formed in BM specimens was approximately 60% of IR and preserved the epithelial thickness. Consistent with this appearance, histological analysis shows that tongues of BM demonstrated an increased level of tissue regenerative activity such as blood vessel formation and cell proliferation. Finally, after 11 days of irradiation, the area of ulcers in BM decreased remarkably compared with that in IR. Our data suggests that cell therapy with BMDCs can prevent the maximum ulceration caused by head and neck irradiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
放射線性口腔粘膜炎に対する骨髄由来細胞治療の可能性について
骨髓源性细胞治疗放射性口腔粘膜炎的可能性
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[児嶋由子, 柳田学, 森健太, 野崎剛徳, 山田聡, 北村正博, 村上伸也, Shinya Murakami, 井隆司]
通讯作者:
井隆司
放射線性の口腔内障害に対する骨髄由来幹細胞治療応用の検討
骨髓干细胞治疗放射性口腔病变的应用探讨
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[井隆司, 住田吉慶, 大場誠悟, 南里篤太郎, 朝比奈泉]
通讯作者:
朝比奈泉
DOI:
10.1016/j.archoralbio.2011.04.012
发表时间:
2011-11
期刊:
Archives of oral biology
影响因子:
3
作者:
[M. Uehara;H. Ikeda;M. Nonaka;Y. Sumita;A. Nanashima;T. Nonaka;I. Asahina]
通讯作者:
M. Uehara;H. Ikeda;M. Nonaka;Y. Sumita;A. Nanashima;T. Nonaka;I. Asahina
Marginal mandibulectomy for lower gingical carcinoma with a cheek-splitting transbuccal approach and reconstruction by buccal fat pad flap: a case report
颊裂入路颊脂垫瓣重建下颌骨边缘切除术治疗下牙龈癌:一例报告
DOI:
--
发表时间:
2013
期刊:
J Oral Maxillofac Surg
影响因子:
--
作者:
[Ohba S, Yamashita H, Takashi I, Asahina I]
通讯作者:
Asahina I
DOI:
10.1371/journal.pone.0040833
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Zhong W, Sumita Y, Ohba S, Kawasaki T, Nagai K, Ma G, Asahina I]
通讯作者:
Asahina I
海外基金